Research Highlight

Inhibiting lysosomal aldolase: a magic bullet for AMPK activation in treating metabolic disease?

  • David Carling
Expand
  • MRC London Institute of Medical Sciences, Imperial College, London W12 0NN, UK
dcarling@imperial.ac.uk

Received date: 19 Sep 2022

Accepted date: 06 Oct 2022

Published date: 15 Dec 2022

Copyright

2022 The Author(s) 2022. Published by Oxford University Press on behalf of Higher Education Press.

Cite this article

David Carling . Inhibiting lysosomal aldolase: a magic bullet for AMPK activation in treating metabolic disease?[J]. Life Metabolism, 2022 , 1(3) : 209 -210 . DOI: 10.1093/lifemeta/loac027

1
Steinberg GR , Carling D . Nat Rev Drug Discov 2019; 18: 527- 51.

2
Zhang CS , Li M , Wang Y et al. Nat Metab 2022; 4: 1369- 401.

3
Zhang CS , Hawley SA , Zong Y et al. Nature 2017; 548: 112- 6.

4
Zhang YL , Guo H , Zhang CS et al. Cell Metab 2013; 18: 546- 55.

5
Li M , Zhang CS , Feng JW et al. Cell Metab 2019; 30: 508- 24.

6
Zong Y , Zhang CS , Li M et al. Cell Res 2019; 29: 460- 73.

7
Gluais-Dagorn P , Foretz M , Steinberg GR et al. Hepatol Commun 2022; 6: 101- 19.

8
Myers RW , Guan HP , Ehrhart J et al. Science 2017; 357: 507- 11.

9
Pollard AE , Martins L , Muckett PJ et al. Nat Metab 2019; 1: 340- 9.

10
Apfeld J , O’Connor G , McDonagh T et al. Genes Dev 2004; 18: 3004- 9.

Outlines

/